LGC and Pharmidex form strategic alliance
LGC and Pharmidex, the London-based neuroscience research service provider, have formed a strategic alliance that raises the standard for DMPK (Drug metabolism and Pharmacokinetics) screening services to drug discovery companies.
Factors related to DMPK - the science of how molecules are broken down by the body and how long they stay in the bloodstream - are the major contributors to compound attrition. For this reason a reliable DMPK profile of compounds early in the drug discovery cycle is essential - it has the potential to save time, eliminate waste and thus add value to the drug discovery process.
By bringing together the world class bioanalytical capabilities of LGC with the pharmacology and drug discovery expertise of Pharmidex, the alliance will deliver a breadth and depth of DMPK service which will be hard to match. The partnership provides drug discovery companies with a very comprehensive offering - in silico, in vitro and beyond - across the whole drug discovery value chain, and is backed by a level of knowledge that is not commonly available in service companies.
Most read news
Other news from the department business & finance
These products might interest you

Milli-Q® Services / MyMilli-Q™ by Merck Life Science
Services & Support for Water Purification Systems
Quality Care, Delivered. In Person & Online

Good Weighing Practice by Mettler-Toledo
Your Concrete Weighing Quality Assurance Plan
GWP Verification service

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Adam Chong named new CEO of Rigaku Asia Pacific
Bayer MaterialScience and Add-Vision sign license agreement on polymeric OLEDs
Lanxess Continues Expansion in China - Investing in the Shanghai and Wuxi sites

WSB Labor GmbH - Krems-Stein, Austria
Moving liquid metal marbles

Rocket fuel that's cleaner, safer and still full of energy

Mismatched alloys are a good match for thermoelectrics
